|
Friday, February 9, 2007
|
|
Breakfast Symposium: Controversies Surrounding the Cardiometabolic Syndrome – Moderator Dr. Basile
|
|
8:00-9:30 am
|
Overview of the Cardiometabolic Syndrome
|
Dr. Vinik
|
|
|
Assessing Risk in the Cardiometabolic Syndrome-Convenient Packaging or a Specific Syndrome?
|
Dr. Fonseca
|
|
|
Ask the Experts Panel
|
Drs. Vinik and Fonseca
|
|
9:30-10:00 am
|
Break
|
|
|
Symposium: Diabetes and the Cardiometabolic Syndrome – Moderator Dr. Piziak
|
|
10:00-12:00 Noon
|
The Link Between Diabetes and The Cardiometabolic Syndrome
|
Dr. Blonde
|
|
|
Do Current Guidelines Identify Cardiometabolic Risk?
|
Dr. Fonseca
|
|
|
The Role of Incretins and Other New Therapies in Modulating the Cardiometabolic Syndrome
|
Dr. Blonde
|
|
|
Q&A with Audience
|
Drs. Blonde and Fonseca
|
|
12:00-12:15 pm
|
Break
|
|
|
Lunch Breakout Sessions
|
|
12:15-1:15 pm
|
A – Should We Measure Inflammatory Biomarkers in Those with the Cardiometabolic Syndrome?
|
Dr. Fonseca
|
|
|
B – Identification and Management of Neuropathy in the Cardiometabolic Syndrome
|
Dr. Vinik
|
|
|
C – Differences in Utilizing Evidence-Based Strategies in Treating Type 2 Diabetes by Specialty
|
Dr. Basile
|
|
|
D – Polycystic Ovary Syndrome and its Relationship to Cardiometabolic Syndrome
|
Dr. Piziak
|
|
Plenary Session: Disparities in Healthcare – Moderator: Dr. Basile
|
|
1:15-2:15 pm
|
Ethnicity and the Cardiometabolic Syndrome
|
Dr. Ferdinand
|
|
Afternoon Symposium: The Cardiometabolic Syndrome in Children – Moderator Dr. Piziak
|
|
2:15-4:15 pm
|
Lessons from the Bogalusa Heart Study
|
Dr. Berenson
|
|
|
The Minority Issues in Pediatric and Adolescent Medicine
|
Dr. D. Wilson
|
|
|
Cardiometabolic Syndrome in Children: Treatment and Intervention
|
Dr. McNeal
|
|
|
Q&A with Audience
|
All Faculty
|
|
Saturday, February 10, 2007
|
|
Breakfast Symposium – Obesity and The Cardiometabolic Syndrome – Moderator Dr. Piziak
|
|
8:00-9:30 am
|
Current and Emerging Therapies for Obesity
|
Dr. Niswender
|
|
|
What is the Role of Surgery in Treating Obesity in the Cardiometabolic Syndrome?
|
Dr. MacDonald
|
|
|
Q&A with Audience
|
Drs. Niswender and MacDonald
|
|
9:30-10:00 am
|
Break
|
|
|
Breakout Sessions: A or B
|
|
10:00-11:30 am
|
A: Practical Applications for Change
|
|
|
|
Individualizing a Nutritional Plan for Change
|
Dr. Piziak
|
|
|
Strategies for Improving Patient Compliance to Diet, Lifestyle, and Medical Therapies
|
Ms. Miller
|
|
|
Implementation of Community Programs to Treat Cardiometabolic Syndrome
|
Ms. Denison
|
|
|
B: New Drugs Update
|
|
|
|
Reviewing the Drugs Utilized in the Cardiometabolic Syndrome
|
Dr. Weart
|
|
|
|
11:30-11:45 am
|
Break
|
|
|
Lunch Symposium: Preventing the Cardiometabolic Syndrome – Moderator Dr. Piziak
|
|
11:45-1:15 pm
|
How Can The Cardiometabolic Syndrome Be Prevented in the US? Reporting from the CDC
|
Dr. Vinicor
|
|
|
Panel Discussion
|
Drs. Dipette, Piziak, and Basile, Ms. Miller, Ms. Denison
|
|
Afternoon Symposium – Cardiovascular Disease and The Cardiometabolic Syndrome – Moderator Dr. Basile
|
|
1:15-3:15 pm
|
The Importance of Treating Pre-Hypertension and Hypertension
|
Dr. Dipette
|
|
|
Hypertension: The Role of RAS in Cardiometabolic Syndrome
|
Dr. Dipette
|
|
|
Global CV Management in the Diabetic Patient: Does it apply to those with the Cardiometabolic Syndrome?
|
Dr. Basile
|
|
|
Q&A with Audience
|
Drs. Dipette and Basile
|
|
Sunday, February 11, 2007
|
|
Breakfast Symposium – More Controversial Issues Surrounding the Cardiometabolic Syndrome – ModeratorDr. Basile
|
|
8:00-10:00 am
|
The Importance of Treating Lipids
|
Dr. P. Wilson
|
|
|
What is the Role of Endothelial Dysfunction in Cardiometabolic Risk?
|
Dr. Giles
|
|
|
The Role of Biomarkers in the Cardiometabolic Syndrome`
|
Dr. P. Wilson
|
|
10:00-10:15
|
What We’ve Learned – Wrap Up Session
|
Dr. Basile
|
|
10:45-11:00 am
|
Q&A with Audience
|
All Faculty
|
